Effect of Probenecid on the Kinetics of a Single Oral 400mg Dose of Moxifloxacin in Healthy Male Volunteers
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (1) , 71-76
- https://doi.org/10.2165/00003088-200140001-00010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in manJournal of Antimicrobial Chemotherapy, 1999
- Absolute bioavailability of moxifloxacinClinical Therapeutics, 1999
- Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterialExpert Opinion on Investigational Drugs, 1999
- A Review of the Clinical Pharmacology of Moxifloxacin, a New 8-Methoxyquinolone, and its Potential Relation to Therapeutic EfficacyClinical Drug Investigation, 1999
- The Clinical Pharmacokinetics of LevofloxacinClinical Pharmacokinetics, 1997
- Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humansAntimicrobial Agents and Chemotherapy, 1995
- Effect of probenecid on the distribution and elimination of ciprofloxacin in humansClinical Pharmacology & Therapeutics, 1995
- Pharmacokinetics and the Effect of Probenecid on the Renal Excretion Mechanism of DiprophyllineJournal of Pharmaceutical Sciences, 1992
- The pharmacokinetics of meropenem in volunteersJournal of Antimicrobial Chemotherapy, 1989
- Effect of probenecid on the disposition of captopril and captopril dimer in the ratBiochemical Pharmacology, 1985